Literature DB >> 23623839

Production of Cyr61 protein is modulated by extracellular acidification and PI3K/Akt signaling in prostate carcinoma PC-3 cells.

Yoon-Jin Lee1, David M Lee, Sang-Han Lee.   

Abstract

High expression of Cyr61, an extracellular cysteine-rich heparin-binding protein, has been associated with a malignant cell phenotype and poor outcome in prostate cancers. Although Cyr61 was found by us to be overproduced in androgen-independent PC-3 cells treated with N-acetylcysteine (NAC), its significance is still unclear. We therefore aimed to determine how and why Cyr61 protein is overexpressed in NAC-treated cells. Here, we found that Cyr61 protein level markedly increased in cells treated with NAC at high cell seeding density. Silencing of Cyr61 by siRNA induced enhanced activity of caspase-3/7, upregulation of the proapototic Bok, BimL and BimS, cleavage of apoptosis hallmarkers such as Bax, PARP and caspase-3, and downregulation of antiapoptotic Bcl2, Bcl-xL and Mcl-1 proteins. NAC treatment caused a reduction of extracellular medium pH to acidic and an increase in Akt phosphorylation, after which the replacement with NAC-free medium returned them to control levels within 24h. Acid stimulation increased the levels of Cyr61 and p-Akt proteins, whereas it suppressed the induction of proapoptotic and antiapoptotic proteins. Overall, our data indicate that PC-3 cells overproduce Cyr61 protein via activation of the PI3K/Akt signaling as a part of the survival mechanisms under the conditions causing extracellular acidity and further cytotoxicity.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Akt; Apoptotic cell death; Cyr61; ECL; ECM; Extracellular acidity; HRP; N-acetylcysteine; NAC; PBS; PI3K; Prostate cancer; SDS; c-FLIP; cellular FLICE-like inhibitory protein; enhanced chemiluminescence; extracellular matrix; horseradish peroxidase; p-Akt; phosphate buffered saline; phosphoinositide 3-kinase; phosphor-Akt; serine/threonine protein kinase B; siRNA; small interfering RNA; sodium dodecyl sulfate

Mesh:

Substances:

Year:  2013        PMID: 23623839     DOI: 10.1016/j.fct.2013.04.035

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  6 in total

1.  Dexamethasone and lenvatinib inhibit migration and invasion of non-small cell lung cancer by regulating EKR/AKT and VEGF signal pathways.

Authors:  Daye Zhang; Yongxiang Zhang; Zeyuan Cai; Ying Tu; Zhansong Hu
Journal:  Exp Ther Med       Date:  2019-11-21       Impact factor: 2.447

2.  Cyr61: a potential therapeutic target for prostate cancer.

Authors:  Chang-Ming Lin; Chao-Zhao Liang
Journal:  Asian J Androl       Date:  2014 Sep-Oct       Impact factor: 3.285

3.  Dexamethasone Inhibits TGF-β1-Induced Cell Migration by Regulating the ERK and AKT Pathways in Human Colon Cancer Cells Via CYR61.

Authors:  Sanghoon Han; Ngoc Thuy Bui; Manh Tin Ho; Young Mee Kim; Moonjae Cho; Dong Bok Shin
Journal:  Cancer Res Treat       Date:  2015-12-15       Impact factor: 4.679

4.  Cariporide Enhances the DNA Damage and Apoptosis in Acid-tolerable Malignant Mesothelioma H-2452 Cells.

Authors:  Yoon-Jin Lee; Jin-Ho Bae; Soo-A Kim; Sung-Ho Kim; Kee-Min Woo; Hae-Seon Nam; Moon-Kyun Cho; Sang-Han Lee
Journal:  Mol Cells       Date:  2017-08-10       Impact factor: 5.034

5.  7,8-DHF Treatment Induces Cyr61 Expression to Suppress Hypoxia Induced ER Stress in HK-2 Cells.

Authors:  Rui Ma; Jisheng Zhang; Xiaoyu Liu; Shaoheng Yue; Qing Zhao; Yan Xu
Journal:  Biomed Res Int       Date:  2016-12-27       Impact factor: 3.411

6.  Targeting cysteine-rich angiogenic inducer-61 by antibody immunotherapy suppresses growth and migration of non-small cell lung cancer.

Authors:  Xinpeng Li; Naxin Yuan; Lingdan Lin; Lixia Yin; Yiqing Qu
Journal:  Exp Ther Med       Date:  2018-06-08       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.